Amedeo Smart

Free Medical Literature Service



Alzheimer's Disease

  Free Subscription

Articles published in
Neurosci Lett
    September 2022
  1. LANG W, Li X, Wang Y, Duan Y, et al
    Sodium propionate improves cognitive and memory function in mouse models of Alzheimer's disease.
    Neurosci Lett. 2022 Sep 26:136887. doi: 10.1016/j.neulet.2022.136887.
    >> Share

  2. TONDELLI M, Salemme S, Vinceti G, Bedin R, et al
    Predictive value of phospho-tau/total-tau ratio in amyloid-negative Mild Cognitive Impairment.
    Neurosci Lett. 2022;787:136811.
    >> Share

    August 2022
  3. LONG Y, Cheng Y, Yang J, Yang T, et al
    Abeta-induced presynaptic release of UBC9 through extracellular vesicles involves SNAP23.
    Neurosci Lett. 2022;785:136771.
    >> Share

    July 2022
  4. RONG Y, Mi X, Ni C, Liu T, et al
    Protective effect of vitamin C on DNA damage in surgery-induced cognitive dysfunction in APP/PS1 mice.
    Neurosci Lett. 2022;784:136740.
    >> Share

  5. LIN J, Niu Z, Xue Y, Gao J, et al
    Chronic vitamin D3 supplementation alleviates cognition impairment via inhibition of oxidative stress regulated by PI3K/AKT/Nrf2 in APP/PS1 transgenic mice.
    Neurosci Lett. 2022;783:136725.
    >> Share

  6. KOCA S, Kiris I, Sahin S, Cinar N, et al
    Decreased levels of cytokines implicate altered immune response in plasma of moderate-stage Alzheimer's disease patients.
    Neurosci Lett. 2022 Jul 13:136799. doi: 10.1016/j.neulet.2022.136799.
    >> Share

  7. ZHANG Y, Liu D, Yao X, Wen J, et al
    DMTHB ameliorates memory impairment in Alzheimer's disease mice through regulation of neuroinflammation.
    Neurosci Lett. 2022 Jul 7:136770. doi: 10.1016/j.neulet.2022.136770.
    >> Share

    June 2022
  8. WANG J, Wen C, Li J, Chen J, et al
    Automated quantification of brain connectivity in Alzheimer's disease using ClusterMetric.
    Neurosci Lett. 2022 Jun 10:136724. doi: 10.1016/j.neulet.2022.136724.
    >> Share

  9. MA X, Liu L, Meng J
    Retraction notice to "MicroRNA-125b promotes neurons cell apoptosis and tau phosphorylation in Alzheimer's disease" [Neurosci. Lett. 661 (2017) 57-62].
    Neurosci Lett. 2022;783:136703.
    >> Share

  10. AAMERI R, Ghorbani H, Reza Bazrafshan H, Zahra Gharib F, et al
    Iranian thyme honey plays behavioral, cellular and molecular important roles as an amazing preventive and therapeutic agent in the brain of Alzheimer's rat model.
    Neurosci Lett. 2022;783:136702.
    >> Share

    May 2022
  11. HU Y, Wen C, Cao G, Wang J, et al
    Brain network connectivity feature extraction using deep Learning for Alzheimer's disease classification.
    Neurosci Lett. 2022 May 2:136673. doi: 10.1016/j.neulet.2022.136673.
    >> Share

    April 2022
  12. WANG Y, Yang Y, Liu Y, Guo A, et al
    Cognitive impairments in type 1 diabetes mellitus model mice are associated with synaptic protein disorders.
    Neurosci Lett. 2022;777:136587.
    >> Share

    February 2022
  13. PIJEWSKI RS, Sutter PA, Duszak VA, Singh N, et al
    Distinct profiles of cellular senescence-associated gene expression in the aged, diseased or injured central nervous system.
    Neurosci Lett. 2022;772:136480.
    >> Share

  14. LI Y, Han X, Fan H, Sun J, et al
    Circular RNA AXL increases neuron injury and inflammation through targeting microRNA-328 mediated BACE1 in Alzheimer's disease.
    Neurosci Lett. 2022 Feb 12:136531. doi: 10.1016/j.neulet.2022.136531.
    >> Share

  15. AN Y, Qi Y, Li Y, Li Z, et al
    Activation of the sigma-1 receptor attenuates blood-brain barrier disruption by inhibiting amyloid deposition in Alzheimer's disease mice.
    Neurosci Lett. 2022 Feb 11:136528. doi: 10.1016/j.neulet.2022.136528.
    >> Share

    January 2022
  16. IMA X, Liu L, Meng J
    Expression of concern: MicroRNA-125b promotes neurons cell apoptosis and tau phosphorylation in Alzheimer's disease.
    Neurosci Lett. 2022;769:136229.
    >> Share

  17. CHENFEI Z, Haizhen Y, Jie X, Na Z, et al
    Effects of aerobic exercise on hippocampal SUMOylation in APP/PS1 transgenic mice.
    Neurosci Lett. 2022;767:136303.
    >> Share

  18. QIAN C, Zhang M
    RTN3 - ASC interaction: The potential mechanism behind diabetes-induced cortical neuritic dystrophy.
    Neurosci Lett. 2022;766:136333.
    >> Share

    December 2021
  19. XUE YY, Chen YH, Lin RR, Huang HF, et al
    Alzheimer's disease susceptibility locus in CD2AP is associated with increased cerebrospinal fluid tau levels in mild cognitive impairment.
    Neurosci Lett. 2021 Dec 24:136419. doi: 10.1016/j.neulet.2021.136419.
    >> Share

  20. WANG M, Ren Q, Shi Y, Shu H, et al
    The Effect of Alzheimer's Disease Risk Factors on Brain Aging in normal Chineses: Cognitive Aging and Cognitive Reserve.
    Neurosci Lett. 2021 Dec 16:136398. doi: 10.1016/j.neulet.2021.136398.
    >> Share

  21. LAI X, Hu J, Liu H, Lan L, et al
    A short peptide from sAPPalpha binding to BACE1-APP action site rescues Alzheimer-like pathology.
    Neurosci Lett. 2021 Dec 13:136397. doi: 10.1016/j.neulet.2021.136397.
    >> Share

    November 2021
  22. GEORGE B, D Gokhale S, Yaswanth PM, Vijayan A, et al
    Identification of Alzheimer associated differentially expressed gene through microarray data and transfer learning-based image analysis.
    Neurosci Lett. 2021;766:136357.
    >> Share

  23. ZHOU X, Wang Y, Lv S, Li Y, et al
    Transcranial magnetic stimulation for sleep disorders in Alzheimer's disease: A double-blind, randomized, and sham-controlled pilot study.
    Neurosci Lett. 2021;766:136337.
    >> Share

  24. ZHANG Y, Zhao Y, Zhang J, Gao Y, et al
    Ginkgolide B inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization in Abeta1-42-induced microglia cells.
    Neurosci Lett. 2021;764:136206.
    >> Share

    October 2021
  25. ZHU Z, Liu Y, Li X, Zhang L, et al
    GPNMB mitigates Alzheimer's disease and enhances autophagy via suppressing the mTOR signal.
    Neurosci Lett. 2021 Oct 22:136300. doi: 10.1016/j.neulet.2021.136300.
    >> Share

  26. BANG S, Kuen Song J, Shin SW, Hee Lee K, et al
    Human Serum Albumin Fusion Protein as Therapeutics for Targeting Amyloid Beta in Alzheimer's Diseases.
    Neurosci Lett. 2021 Oct 18:136298. doi: 10.1016/j.neulet.2021.136298.
    >> Share

    September 2021
  27. CASTILLO-MARIQUEO L, Gimenez-Llort L
    Kyphosis and bizarre patterns impair spontaneous gait performance in end-of-life mice with Alzheimer's disease pathology while gait is preserved in normal aging.
    Neurosci Lett. 2021 Sep 30:136280. doi: 10.1016/j.neulet.2021.136280.
    >> Share

  28. GAO F, Liu T, Tuo M, Chi S, et al
    The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target.
    Neurosci Lett. 2021;765:136247.
    >> Share

  29. LU X, Zhang Y, Li H, Jin Y, et al
    Nicotine prevents in vivo Abeta toxicity in Caenorhabditis elegans via SKN-1.
    Neurosci Lett. 2021;761:136114.
    >> Share

  30. KURIMOTO E, Yamada R, Hirakawa T, Kimura H, et al
    Therapeutic Potential of TAK-071, a Muscarinic M1 Receptor Positive Allosteric Modulator with Low Cooperativity, For the Treatment of Cognitive Deficits and Negative Symptoms Associated with Schizophrenia.
    Neurosci Lett. 2021 Sep 9:136240. doi: 10.1016/j.neulet.2021.136240.
    >> Share

  31. RADAGHDAM S, Karamad V, Nourazarian A, Shademan B, et al
    Molecular mechanisms of sex hormones in the development and progression of Alzheimer's disease.
    Neurosci Lett. 2021 Sep 6:136221. doi: 10.1016/j.neulet.2021.136221.
    >> Share

    August 2021
  32. RIZZI L, Balthazar MLF
    Mini-review: The suspected non-Alzheimer's disease pathophysiology.
    Neurosci Lett. 2021 Aug 31:136208. doi: 10.1016/j.neulet.2021.136208.
    >> Share

  33. KIM TA, Chen L, Ge S
    The interplay of neurovasculature and adult hippocampal neurogenesis.
    Neurosci Lett. 2021;760:136071.
    >> Share

  34. WEI X, Xie L, Du P, Zhao Z, et al
    Impacts of DNA methylation on Tau protein related genes in the brains of patients with Alzheimer's Disease.
    Neurosci Lett. 2021 Aug 23:136196. doi: 10.1016/j.neulet.2021.136196.
    >> Share

  35. ZHAO N, Xu B
    The beneficial effect of exercise against Alzheimer's disease may result from improved brain glucose metabolism.
    Neurosci Lett. 2021 Aug 18:136182. doi: 10.1016/j.neulet.2021.136182.
    >> Share

    July 2021
  36. SHENG J, Wang L, Cheng H, Zhang Q, et al
    Strategies for multivariate analyses of imaging genetics study in Alzheimer's disease.
    Neurosci Lett. 2021;762:136147.
    >> Share

  37. YUE L, Liu P, Ma N, Xu Y, et al
    Interaction between extracellular ATP5A1 and LPS alleviates LPS-induced neuroinflammation in mice.
    Neurosci Lett. 2021;758:136005.
    >> Share

  38. AREZOUMANDAN S, Cai X, Kalkarni P, Davis SA, et al
    Hippocampal neurobiology and function in an aged mouse model of TDP-43 proteinopathy in an APP/PSEN1 background.
    Neurosci Lett. 2021;758:136010.
    >> Share

  39. SUN B, Yao J, Chen AW, Estillore JP, et al
    Genetically and pharmacologically limiting RyR2 open time prevents neuronal hyperactivity of hippocampal CA1 neurons in brain slices of 5xFAD mice.
    Neurosci Lett. 2021;758:136011.
    >> Share

  40. WANDER CM, Song J
    The Neurogenic Niche in Alzheimer's disease.
    Neurosci Lett. 2021 Jul 13:136109. doi: 10.1016/j.neulet.2021.136109.
    >> Share

    June 2021
  41. SINGULANI MP, De Paula VJR, Forlenza OV
    Mitochondrial dysfunction in Alzheimer's disease: therapeutic implications of lithium.
    Neurosci Lett. 2021 Jun 20:136078. doi: 10.1016/j.neulet.2021.136078.
    >> Share

  42. HAUSSMANN R, Noppes F, Brandt MD, Bauer M, et al
    Lithium: A therapeutic option in Alzheimer's disease and its prodromal stages?
    Neurosci Lett. 2021 Jun 10:136044. doi: 10.1016/j.neulet.2021.136044.
    >> Share

  43. ANDROVICOVA R, Pfaus JG, Ovsepian SV
    Estrogen Pendulum in Schizophrenia and Alzheimer's Disease: Review of Therapeutic Benefits and Outstanding Questions.
    Neurosci Lett. 2021 Jun 8:136038. doi: 10.1016/j.neulet.2021.136038.
    >> Share

    May 2021
  44. DAINI E, Secco V, Liao W, Zoli M, et al
    A regional and cellular analysis of the early intracellular and extracellular accumulation of Abeta in the brain of 5XFAD mice.
    Neurosci Lett. 2021;754:135869.
    >> Share

  45. HE B, Wang L, Xu B, Zhang Y, et al
    Association between CSF Abeta42 and amyloid negativity in patients with different stage mild cognitive impairment.
    Neurosci Lett. 2021;754:135765.
    >> Share

  46. LAKSHMI S, Raghu SV, Elumalai P, Sivan S, et al
    Alkoxylglycerol enhanced activity of Oxyresveratrol in Alzheimer's disease by rescuing Tau protein.
    Neurosci Lett. 2021 May 20:135981. doi: 10.1016/j.neulet.2021.135981.
    >> Share

  47. ZARETSKY DV, Zaretskaia MV
    Mini-review: Amyloid degradation toxicity hypothesis of Alzheimer's disease.
    Neurosci Lett. 2021;756:135959.
    >> Share

  48. ZHANG H, Ge H, Li K
    Aberrant expression of miR-148a-3p in Alzheimer's disease and its protective role against amyloid-beta induced neurotoxicity.
    Neurosci Lett. 2021 May 9:135953. doi: 10.1016/j.neulet.2021.135953.
    >> Share

  49. SHAMSIPOUR S, Sharifi G, Taghian F
    Impact of interval training with probiotic (L. plantarum / Bifidobacterium bifidum) on passive avoidance test, ChAT and BDNF in the hippocampus of rats with Alzheimer's disease.
    Neurosci Lett. 2021;756:135949.
    >> Share

    April 2021
  50. ARIOZ BI, Tufekci KU, Olcum M, Durur DY, et al
    Proteome profiling of neuron-derived exosomes in Alzheimer's disease reveals hemoglobin as a potential biomarker.
    Neurosci Lett. 2021;755:135914.
    >> Share

  51. OVSEPIAN SV, O'Leary VB, Hoschl C, Zaborszky L, et al
    Integrated Phylogeny of the Human Brain and Pathobiology of Alzheimer's Disease: A Unifying Hypothesis.
    Neurosci Lett. 2021 Apr 13:135895. doi: 10.1016/j.neulet.2021.135895.
    >> Share

  52. GKANATSIOU E, Sahlin C, Portelius E, Johannesson M, et al
    Characterization of monomeric and soluble aggregated Abeta in Down's syndrome and Alzheimer's disease brains.
    Neurosci Lett. 2021 Apr 10:135894. doi: 10.1016/j.neulet.2021.135894.
    >> Share

  53. RASHTIANI S, Goudarzi I, Jafari A, Rohampour K, et al
    Adenosine monophosphate activated protein kinase (AMPK) is essential for the memory improving effect of adiponectin.
    Neurosci Lett. 2021;749:135721.
    >> Share

    February 2021
  54. SANTOS-GIL DF, Arboleda G, Sandoval-Hernandez AG
    Retinoid X Receptor activation promotes re-myelination in a very old triple transgenic mouse model of Alzheimer's disease.
    Neurosci Lett. 2021 Feb 20:135764. doi: 10.1016/j.neulet.2021.135764.
    >> Share

  55. GIL L, Nino SA, Capdeville G, Jimenez-Capdeville ME, et al
    Neurosci Lett. 2021 Feb 18:135741. doi: 10.1016/j.neulet.2021.135741.
    >> Share

    Evaluation of fluid channels in the human dura and superior sagittal sinus in older patients.
    Neurosci Lett. 2021;746:135649.
    >> Share

  57. LIM KH, Kim SH, Yang S, Chun S, et al
    Advances in multiplex PCR for Alzheimer's disease diagnostics targeting CDK genes.
    Neurosci Lett. 2021 Feb 15:135715. doi: 10.1016/j.neulet.2021.135715.
    >> Share

  58. XU L, Dong Q, Xu L, Zou W, et al
    The MCP-1 A-2518G polymorphism increases the risk of Alzheimer's disease: a case-control study.
    Neurosci Lett. 2021 Feb 9:135710. doi: 10.1016/j.neulet.2021.135710.
    >> Share

    January 2021
  59. LIANG C, Mu Y, Tian H, Wang D, et al
    MicroRNA-140 silencing represses the incidence of Alzheimer's disease.
    Neurosci Lett. 2021 Jan 30:135674. doi: 10.1016/j.neulet.2021.135674.
    >> Share

  60. ZHANG B, Wu L, Zhu Q, Dong Y, et al
    Donepezil attenuates the development of morphine tolerance in rats with cancer-induced bone pain: the role of cortical N-methyl-D-aspartate receptors.
    Neurosci Lett. 2021 Jan 28:135678. doi: 10.1016/j.neulet.2021.135678.
    >> Share

  61. WANG Y, Sheng H, Zhao J, Guo L, et al
    Changes in the prefrontal cortex after the hippocampus was injected with Abeta25-35 via the P35/P25-CDK5-Tau hyperphosphorylation signaling pathway.
    Neurosci Lett. 2021;741:135453.
    >> Share

  62. DIXIT MP, Rahmatkar SN, Raut P, Umekar MJ, et al
    Evidences for agmatine alterations in Abeta1-42induced memory impairment in mice.
    Neurosci Lett. 2021;740:135447.
    >> Share

    December 2020
  63. WANG J, Guo MN, Liu ZZ, Ma SF, et al
    PGC-1alpha reduces Amyloid-beta deposition in Alzheimer's disease: Effect of increased VDR expression.
    Neurosci Lett. 2020;744:135598.
    >> Share

  64. TIAN Z, Dong Q, Wu T, Guo J, et al
    MicroRNA-20b-5p aggravates neuronal apoptosis induced by beta-Amyloid via down-regulation of Ras homolog family member C in Alzheimer's disease.
    Neurosci Lett. 2020 Dec 2:135542. doi: 10.1016/j.neulet.2020.135542.
    >> Share

    November 2020
  65. SONG X, Chen J, Hou Z, Xie N, et al
    Antimicrobial therapy and the potential mechanisms in Alzheimer's disease.
    Neurosci Lett. 2020 Nov 6:135464. doi: 10.1016/j.neulet.2020.135464.
    >> Share

    September 2020
  66. ZHAO A, Li Y, Deng Y
    TNF receptors are associated with tau pathology and conversion to Alzheimer's dementia in subjects with mild cognitive impairment.
    Neurosci Lett. 2020 Sep 15:135392. doi: 10.1016/j.neulet.2020.135392.
    >> Share

    June 2020
  67. TANG Y, Han Y, Yu H, Zhang B, et al
    Increased GABAergic Development in iPSC-Derived Neurons from Patients with Sporadic Alzheimer's Disease.
    Neurosci Lett. 2020 Jun 29:135208. doi: 10.1016/j.neulet.2020.135208.
    >> Share

    May 2020
  68. LIM B, Li QX, Rowe C, Dhiman K, et al
    Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Abeta load and cerebrospinal fluid Abeta in a pilot study of Alzheimer's disease.
    Neurosci Lett. 2020 May 22:135078. doi: 10.1016/j.neulet.2020.135078.
    >> Share

  69. LIU HJ, Li XY, Chen H, Yu HL, et al
    Identification of susceptibility loci for cognitive impairment in a cohort of Han Chinese patients with Parkinson's disease.
    Neurosci Lett. 2020 May 10:135034. doi: 10.1016/j.neulet.2020.135034.
    >> Share

  70. DOULAH A, Mahmoodi G, Borujeni MP
    Evaluation of the Pre-Treatment Effect of Centella Asiatica Medicinal Plants on Long-Term potentiation (LTP) in Rat Model of Alzheimer's Disease.
    Neurosci Lett. 2020 May 5:135026. doi: 10.1016/j.neulet.2020.135026.
    >> Share

  71. KONG Y, Peng Q, Lv N, Yuan J, et al
    Paeoniflorin exerts neuroprotective effects in a transgenic mouse model of Alzheimer's disease via activation of adenosine A1 receptor.
    Neurosci Lett. 2020 May 1:135016. doi: 10.1016/j.neulet.2020.135016.
    >> Share

    April 2020
  72. ACERO G, Garay C, Venegas D, Ortega E, et al
    Novel monoclonal antibody 3B8 specifically recognizes pyroglutamate-modified amyloid beta 3-42 peptide in brain of AD patients and 3xTg-AD transgenic mice.
    Neurosci Lett. 2020;724:134876.
    >> Share

  73. LIU Y, Xu Y, Li M, Pan D, et al
    Multi-target PET evaluation in APP/PS1/tau mouse model of Alzheimer's disease.
    Neurosci Lett. 2020 Apr 8:134938. doi: 10.1016/j.neulet.2020.134938.
    >> Share

    February 2020
  74. ZHANG Z, Gao W, Wang X, Zhang D, et al
    Geniposide effectively reverses cognitive impairment and inhibits pathological cerebral damage by regulating the mTOR Signal pathway in APPPS1 mice.
    Neurosci Lett. 2020;720:134749.
    >> Share

    January 2020
  75. LI M, Meng Y, Chu B, Shen Y, et al
    Orexin-A exacerbates Alzheimer's disease by inducing mitochondrial impairment.
    Neurosci Lett. 2020;718:134741.
    >> Share

    December 2019
  76. SUN X, Nie B, Zhao S, Ai L, et al
    Distinct relationships of amyloid-beta and tau deposition to cerebral glucose metabolic networks in Alzheimer's disease.
    Neurosci Lett. 2019;717:134699.
    >> Share

  77. LIU Y, Fang S, Liu LM, Zhu Y, et al
    Hearing loss is an early biomarker in APP/PS1 Alzheimer's disease mice.
    Neurosci Lett. 2019;717:134705.
    >> Share

  78. SINGH A, Agarwal S, Singh S
    Age related neurodegenerative Alzheimer's disease: Usage of traditional herbs in therapeutics.
    Neurosci Lett. 2019 Dec 6:134679. doi: 10.1016/j.neulet.2019.134679.
    >> Share

    November 2019
  79. WANG L, Gao T, Cai T, Li K, et al
    Cerebrospinal fluid levels of YKL-40 in prodromal Alzheimer's disease.
    Neurosci Lett. 2019 Nov 30:134658. doi: 10.1016/j.neulet.2019.134658.
    >> Share

  80. LU X, Moeini M, Li B, Thorin E, et al
    Hypertension accelerates cerebral tissue PO2 disruption in Alzheimer's disease.
    Neurosci Lett. 2019 Nov 11:134626. doi: 10.1016/j.neulet.2019.134626.
    >> Share

    August 2019
  81. NONAKA S, Nakanishi H
    Microglial clearance of focal apoptotic synapses.
    Neurosci Lett. 2019;707:134317.
    >> Share

  82. BALU D, Karstens AJ, Loukenas E, Maldonado Weng J, et al
    The role of APOE in transgenic mouse models of AD.
    Neurosci Lett. 2019;707:134285.
    >> Share

    July 2019
  83. PEREZ-ROCA L, Prada-Dacasa P, Segu-Verges C, Gamez-Valero A, et al
    Glucocerebrosidase regulators SCARB2 and TFEB are up-regulated in Lewy body disease brain.
    Neurosci Lett. 2019;706:164-168.
    >> Share

    June 2019
  84. YAMAGUCHI Y, Ayaki T, Li F, Tsujimura A, et al
    Phosphorylated NF-kappaB subunit p65 aggregates in granulovacuolar degeneration and neurites in neurodegenerative diseases with tauopathy.
    Neurosci Lett. 2019;704:229-235.
    >> Share

    May 2019
  85. XIA W
    gamma-Secretase and its modulators: Twenty years and beyond.
    Neurosci Lett. 2019;701:162-169.
    >> Share

    April 2019
  86. PARKER J, Mozaffar T, Messmore A, Deignan JL, et al
    Homozygosity for the A431E mutation in PSEN1 presenting with a relatively aggressive phenotype.
    Neurosci Lett. 2019;699:195-198.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016